Back to results
US 2021/0270836 A1Published application
Method for the in vitro diagnosis of prostate cancer by means of urinary biomarkers
AssigneeNib Biotec S.R.L.
InventorSergio Occhipinti
Life of this patent
Estimating the term…
Abstract
The present invention concerns a method for the in vitro/ex vivo diagnosis of a prostate cancer and/or the aggressiveness thereof by means of urinary biomarkers.
Claims15
A method for the in vitro/ex vivo diagnosis of a prostate cancer and/or of the aggressiveness thereof in an individual comprising the steps of:
- a) providing a urine sample of the individual;
- b) quantifying the zinc in the urine sample;
- c) comparing the quantified value of zinc with a reference value.
A method for the in vitro/ex vivo diagnosis of a prostate cancer and/or the aggressiveness thereof in an individual comprising the steps of:
- a′) providing a urine sample of the individual;
- b′) quantifying the zinc in the urine sample;
- c′) quantifying in the urine sample a molecule having molecular formula C4H7N3O (creatinine);
- d′) normalizing the quantified value of zinc with the quantified value of a molecule having molecular formula C4H7N3O (creatinine);
- e′) comparing the normalized value of zinc with a reference value.
2 more elements
Dependencies are inferred from the claim text.